| Deler fremragende | 11,374,360 shares |
| Insideraktier | 3.139.776 shares |
| Insider ejerskab | 27,60 % |
| Total Insiders | 25 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
BG Medicine, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Noubar Afeyan
Director, 10% Owner -
[D]
|
0 | 0 | |
| Charles H Jr Abdalian | 140.000 | ||
| Adourian Aram S. SVP & Chief Scientific Officer - [O] | 40.036 | 40.036 | |
| Harrison M Jr Bains | 4.205 | ||
| Stephane Bancel Executive Chairman, Director - [D] [O] | 123.167 | 30.792 | |
| Eric Bouvier President, CEO, Director - [D] [O] | 10.000 | 2.500 | |
| William Densel | 0 | ||
|
Flagship Ventures 2007 General Partner LLC
10% Owner -
|
882.142 | 882.142 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Flagship Ventures Fund 2007, L.P.
10% Owner -
|
882.142 | 882.142 | |
| Neal Gordon | 30.000 | ||
|
Gilde Europe Food & Agribusiness Partners II C.V.
10% Owner -
|
1.635.432 | 408.858 | |
| Stephen P Hall EVP & Chief Financial Officer - [O] | 31.034 | 31.034 | |
| Harris Timothy J.R. | 4.205 | ||
| Jeffrey R Luber | 0 | ||
| Miller Stephen R. | 30.000 | ||
| Pieter Muntendam EVP, Chief Medical Officer - [O] | 78.483 | 19.621 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| James F O Oconnor | 0 | ||
| Stelios Papadopoulos Director - [D] | 1.187.713 | 296.928 | |
| Brian S Posner Director - [D] | 20.000 | 5.000 | |
| Michael W Rogers | 35.000 | ||
| Anastasia Rader | 42.000 | ||
| Paul R Sohmer President & CEO, Director - [D] [O] | 53.161 | 53.161 | |
| Haygood Paterson Sr Seawell - | 1.308.965 | 1.308.965 | |
| Harry W Wilcox | 5.000 | ||
|
der Meer Pieter van
10% Owner -
|
1.635.432 | 408.858 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMD / BG Medicine, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMD / BG Medicine, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr | BGMD | Common Stock | D | 2.587.930 | ||||||||
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr Spouse | BGMD | Common Stock | I | 1.308.965 | ||||||||
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr Spouse | BGMD | Common Stock | I | 1.308.965 | ||||||||
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr | BGMD | Common Stock | D | 2.587.930 | ||||||||
| 2016-05-04 | 2014-04-14 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 0,90 | -12.000 | 16.036 | |||||
| 2016-05-04 | 2014-04-14 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,9000 | 12.000 | 11 | 40.036 | ||||
| 2016-04-04 | 2016-03-31 | 4 | HALL STEPHEN P | BGMD | Common Stock | D | 0,3600 | -8.986 | -3 | 31.034 | ||||
| 2016-04-04 | 2016-03-31 | 4 | SOHMER PAUL R | BGMD | Common Stock | D | 0,3600 | -15.493 | -6 | 53.161 | ||||
| 2016-04-04 | 2016-03-31 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,3600 | -7.456 | -3 | 35.770 | ||||
| 2016-02-05 | 2016-02-04 | 4 | LUBER JEFFREY R | BGMD | Stock option (right to buy) | D | 0,29 | 10.000 | 10.000 | |||||
| 2015-12-11 | 2015-12-09 | 4 | AFEYAN NOUBAR Held by Atlast LP | BGMD | Common Stock | I | 0,5600 | -2.508 | -1 | 0 | ||||
| 2015-12-11 | 2015-12-09 | 4 | AFEYAN NOUBAR | BGMD | Common Stock | D | 0,5600 | -43.930 | -25 | 0 | ||||
| 2015-11-20 | 2015-11-18 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 0,52 | 5.000 | 5.000 | |||||
| 2015-11-20 | 2015-11-18 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 0,52 | 5.000 | 5.000 | |||||
| 2015-11-20 | 2015-11-18 | 4 | OCONNOR JAMES F O | BGMD | Stock Option (right to buy) | D | 0,52 | 12.500 | 12.500 | |||||
| 2015-11-20 | 2015-11-18 | 4 | WILCOX HARRY W | BGMD | Stock Option (right to buy) | D | 0,52 | 5.000 | 5.000 | |||||
| 2015-08-19 | 2015-08-15 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,8300 | -6.233 | -5 | 40.226 | ||||
| 2015-08-19 | 2015-08-15 | 4 | SOHMER PAUL R | BGMD | Common Stock | D | 0,8300 | -13.321 | -11 | 68.654 | ||||
| 2015-08-19 | 2015-08-15 | 4 | HALL STEPHEN P | BGMD | Common Stock | D | 0,8300 | -7.505 | -6 | 39.995 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -8.410 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -53.857 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -530 | -1 | 786.970 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 8.410 | 1 | 787.500 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -3.390 | -8 | 763.330 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 53.857 | 8 | 766.720 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -508 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -3.256 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -32 | -0 | 58.232 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 508 | 0 | 58.264 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -206 | -0 | 56.804 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 3.256 | 0 | 57.010 | ||||
| 2015-07-16 | 3 | Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 882.142 | ||||||||
| 2015-07-16 | 3 | Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 882.142 | ||||||||
| 2015-07-16 | 3 | Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 882.142 | ||||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Series A Preferred Stock | I | 1,7003 | 397.072 | 675 | 497.729 | ||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Series A Preferred Stock | I | 100.657 | 100.657 | ||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Series A Preferred Stock | I | 1,7003 | 53.465 | 91 | 67.018 | ||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Series A Preferred Stock | I | 13.553 | 13.553 | ||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Series A Preferred Stock | I | 1,7003 | 725.725 | 1.234 | 909.696 | ||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Series A Preferred Stock | I | 183.971 | 183.971 | ||||||
| 2015-02-24 | 2015-02-20 | 4 | SOHMER PAUL R | BGMD | Stock Option (right to buy) | D | 0,82 | 200.000 | 200.000 | |||||
| 2015-02-24 | 2015-02-20 | 4 | HALL STEPHEN P | BGMD | Stock Option (right to buy) | D | 0,82 | 140.000 | 140.000 | |||||
| 2015-02-24 | 2015-02-20 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 0,82 | 140.000 | 140.000 | |||||
| 2014-12-11 | 2014-12-11 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 0,3000 | -369.112 | -111 | 0 | ||||
| 2014-12-11 | 2014-12-11 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 0,3000 | -18.468 | -6 | 0 | ||||
| 2014-12-11 | 2014-12-10 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 0,3200 | -109.248 | -35 | 369.112 | ||||
| 2014-12-11 | 2014-12-10 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 0,3200 | -5.472 | -2 | 18.468 | ||||
| 2014-12-11 | 2014-12-09 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 0,3600 | -125.789 | -45 | 478.360 | ||||
| 2014-12-11 | 2014-12-09 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 0,3600 | -6.301 | -2 | 23.940 | ||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR | BGMD | Common Stock | D | 11.190 | 0 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | -703.655 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -12.183 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -12.183 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -12.183 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -5.988 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,04 | -12.021 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -440 | -0 | 703.655 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -440 | -0 | 703.655 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -440 | -0 | 703.655 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 12.183 | 0 | 704.095 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 12.183 | 0 | 704.095 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 12.183 | 0 | 704.095 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -216 | -0 | 668.426 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 5.988 | 0 | 668.642 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -927 | -0 | 662.654 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0400 | 12.021 | 0 | 663.581 | ||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | -98.352 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.724 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.724 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.724 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -847 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,04 | -464 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.352 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.352 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.352 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 1.724 | 0 | 98.415 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 1.724 | 0 | 98.415 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 1.724 | 0 | 98.415 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -31 | -0 | 93.369 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 847 | 0 | 93.400 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -37 | -0 | 92.553 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0400 | 464 | 0 | 92.590 | ||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 592.959 | 604.149 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 11.190 | 11.190 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 29.648 | 30.241 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 593 | 593 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | -98.570 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.729 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.729 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.729 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -850 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,04 | -499 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.570 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.570 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.570 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 1.729 | 0 | 98.633 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 1.729 | 0 | 98.633 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 1.729 | 0 | 98.633 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -32 | -0 | 93.572 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 850 | 0 | 93.604 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -39 | -0 | 92.754 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0400 | 499 | 0 | 92.793 | ||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by Atlast LP | BGMD | Common Stock | I | 10.029 | 10.029 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR | BGMD | Common Stock | D | 164.528 | 175.718 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | -2.484.192 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -17.080 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -17.080 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -17.080 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,4600 | -616 | -0 | 2.484.192 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,4600 | -616 | -0 | 2.484.192 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,0200 | 17.080 | 0 | 2.484.808 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,0200 | 17.080 | 0 | 2.484.808 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,0200 | 17.080 | 0 | 2.484.808 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,4600 | -616 | -0 | 7.298.474 | ||||
| 2014-10-17 | 2014-10-16 | 4 | SOHMER PAUL R | BGMD | Common Stock | D | 327.900 | 327.900 | ||||||
| 2014-10-17 | 2014-10-16 | 4 | HALL STEPHEN P | BGMD | Common Stock | D | 190.200 | 190.200 | ||||||
| 2014-10-17 | 2014-10-16 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 157.800 | 185.836 | ||||||
| 2014-06-05 | 2014-06-03 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | Posner Brian S | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-02-06 | 2014-02-04 | 4 | SOHMER PAUL R | BGMD | Stock Option (right to buy) | D | 1,15 | 250.000 | 250.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 1,15 | 93.000 | 93.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 1,15 | 50.000 | 50.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 1,15 | 42.000 | 42.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 1,15 | 40.000 | 40.000 | |||||
| 2013-12-18 | 2013-12-17 | 4 | HALL STEPHEN P | BGMD | Stock Option (right to buy) | D | 0,89 | 150.000 | 150.000 | |||||
| 2013-11-04 | 2013-11-01 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 0,62 | 101.351 | 101.351 | |||||
| 2013-08-05 | 2013-08-01 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 1,20 | 52.083 | 52.083 | |||||
| 2013-06-14 | 2013-06-12 | 4 | Posner Brian S | BGMD | Stock Option (Right to Buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-05-14 | 2013-05-10 | 4 | SOHMER PAUL R | BGMD | Stock Options (right to buy) | D | 1,67 | 700.000 | 700.000 | |||||
| 2013-05-03 | 2013-05-01 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 1,61 | 39.473 | 39.473 | |||||
| 2013-04-30 | 2013-04-26 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 1,69 | 200.000 | 200.000 | |||||
| 2013-04-30 | 2013-04-26 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 1,69 | 75.000 | 75.000 | |||||
| 2013-02-01 | 2013-01-30 | 4 | PAPADOPOULOS STELIOS | BGMD | Common Stock | D | 2,0000 | 250.000 | 500 | 1.187.713 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 2,0000 | 1.050.000 | 2.100 | 1.764.286 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,0000 | 500.000 | 1.000 | 2.851.447 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,0000 | 75.000 | 150 | 215.013 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 2,0000 | 125.000 | 250 | 651.560 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By NewcoGen Group LLC | BGMD | Common Stock | I | 2,0000 | 250.000 | 500 | 2.434.800 | ||||
| 2012-12-12 | 2012-12-10 | 4 | Abdalian Charles H Jr | BGMD | Stock Option (right to buy) | D | 1,33 | 140.000 | 140.000 | |||||
| 2012-11-20 | 2012-11-19 | 4 | Posner Brian S | BGMD | Common Stock | D | 1,1650 | 10.000 | 12 | 20.000 | ||||
| 2012-11-19 | 2012-11-15 | 4 | Bancel Stephane | BGMD | Common Stock | D | 1,2600 | 100.000 | 126 | 123.167 | ||||
| 2012-10-09 | 2012-10-04 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 3,61 | 40.000 | 40.000 | |||||
| 2012-09-17 | 2012-09-13 | 4 | Bancel Stephane | BGMD | Common Stock | D | 3,7000 | 1.381 | 5 | 23.167 | ||||
| 2012-08-22 | 2012-08-21 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | -298.137 | 0 | ||||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -6.422 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -6.422 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -6.422 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,03 | -2.353 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -23 | -0 | 298.137 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -23 | -0 | 298.137 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0200 | 6.422 | 0 | 298.160 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0200 | 6.422 | 0 | 298.160 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -23 | -0 | 285.339 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0200 | 6.422 | 0 | 285.362 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -13 | -0 | 278.940 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0300 | 2.353 | 0 | 278.953 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Densel William | BGMD | Stock Option (right to buy) | D | 6,90 | 100.000 | 100.000 | |||||
| 2012-06-13 | 2012-06-11 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-13 | 2012-06-11 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-13 | 2012-06-11 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-13 | 2012-06-11 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-11 | 2012-06-08 | 4 | Muntendam Pieter | BGMD | Common Stock | D | 5,2900 | -3.965 | -21 | 78.483 | ||||
| 2012-06-11 | 2012-06-07 | 4 | Muntendam Pieter | BGMD | Common Stock | D | 5,5000 | -30.021 | -165 | 82.448 | ||||
| 2012-06-01 | 2012-05-30 | 4 | Muntendam Pieter | BGMD | Stock Option (right to buy) | D | 0,90 | -100.000 | 82.239 | |||||
| 2012-06-01 | 2012-05-30 | 4 | Muntendam Pieter | BGMD | Common Stock | D | 0,9000 | 100.000 | 90 | 112.469 | ||||
| 2012-05-24 | 2012-05-23 | 4 | Bouvier Eric | BGMD | Common Stock | D | 3,9500 | 10.000 | 40 | 10.000 | ||||
| 2012-05-23 | 2012-05-23 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | -130.867 | 0 | ||||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -7.001 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -7.001 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -7.001 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -2.580 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,03 | -2.497 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -36 | -0 | 130.867 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -36 | -0 | 130.867 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -36 | -0 | 130.867 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 7.001 | 0 | 130.903 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 7.001 | 0 | 130.903 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 7.001 | 0 | 130.903 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -14 | -0 | 109.972 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 2.580 | 0 | 109.986 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -19 | -0 | 107.406 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0300 | 2.497 | 0 | 107.425 | ||||
| 2012-05-23 | 2012-05-22 | 4 | Posner Brian S | BGMD | Common Stock | D | 4,0400 | 10.000 | 40 | 10.000 | ||||
| 2012-05-21 | 2012-05-17 | 4 | Bancel Stephane | BGMD | Common Stock | D | 3,8400 | 5.008 | 19 | 21.786 | ||||
| 2012-04-19 | 2012-04-17 | 4 | van der Meer Pieter By Gilde Europe Food & Agribusiness Fund B.V. | BGMD | Common Stock | I | 6,6000 | -200.000 | -1.320 | 1.635.432 | ||||
| 2012-03-21 | 2012-03-19 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 0,90 | -7.009 | 0 | |||||
| 2012-03-21 | 2012-03-19 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,9000 | 7.009 | 6 | 28.036 | ||||
| 2012-02-29 | 2012-02-27 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-24 | 2012-02-22 | 4 | ROGERS MICHAEL W | BGMD | Stock Option (right to buy) | D | 7,84 | 35.000 | 35.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | GORDON NEAL | BGMD | Stock Option (right to buy) | D | 7,84 | 30.000 | 30.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | Bancel Stephane | BGMD | Common Stock | D | 2.778 | 16.778 | ||||||
| 2012-02-24 | 2012-02-22 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 7,84 | 40.000 | 40.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 7,84 | 30.000 | 30.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | Miller Stephen R. | BGMD | Stock Option (right to buy) | D | 7,84 | 30.000 | 30.000 | |||||
| 2012-02-15 | 2012-02-13 | 4 | Posner Brian S | BGMD | Stock Option (right to buy) | D | 8,27 | 8.410 | 8.410 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
